Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-02-16 1:16 pm Purchase | 13G | QUINCE THERAPEUTICS, INC QNCX | Capital Research Global Investors | 2,605,753 8.8% | 162,839 (+6.67%) | View |
| 2021-02-16 12:34 pm Purchase | 13G | QUINCE THERAPEUTICS, INC QNCX | Capital World Investors | 2,610,237 8.8% | 2,610,237 (New Position) | View |
| 2021-02-12 5:37 pm Sale | 13G | QUINCE THERAPEUTICS, INC QNCX | PFIZER INC PFE | 2,143,372 7.3% | -1,106,601 (-34.05%) | View |
| 2021-02-01 4:25 pm Purchase | 13G | QUINCE THERAPEUTICS, INC QNCX | EPQ LLC CTYM PS | 2,863,096 9.71% | 36,300 (+1.28%) | View |
| 2021-01-28 5:57 pm Sale | 13G | QUINCE THERAPEUTICS, INC QNCX | TAKEDA PHARMACEUTICAL CO LTD TAK | 87,258 0.3% | -2,592,544 (-96.74%) | View |
| 2020-02-14 12:03 pm Purchase | 13G | QUINCE THERAPEUTICS, INC QNCX | Capital Research Global Investors | 2,442,914 9% | 2,442,914 (New Position) | View |
| 2020-02-11 4:38 pm Purchase | 13G | QUINCE THERAPEUTICS, INC QNCX | Lamond David | 1,955,165 6.7% | 30,000 (+1.56%) | View |
| 2020-01-07 1:39 pm Unchanged | 13G | QUINCE THERAPEUTICS, INC QNCX | EPQ LLC CTYM PS | 2,826,796 10.53% | 0 (Unchanged) | View |
| 2019-09-30 08:43 am Purchase | 13G | QUINCE THERAPEUTICS, INC QNCX | LAMOND PIERRE | 2,886,530 10.75% | 2,886,530 (New Position) | View |
| 2019-09-30 08:41 am Purchase | 13G | QUINCE THERAPEUTICS, INC QNCX | Lamond David | 1,925,165 7.17% | 1,925,165 (New Position) | View |
| 2019-06-18 1:53 pm Purchase | 13G | QUINCE THERAPEUTICS, INC QNCX | EPQ LLC CTYM PS | 2,826,796 10.6% | 639 (+0.02%) | View |
| 2019-06-11 11:14 am Purchase | 13G | QUINCE THERAPEUTICS, INC QNCX | EPQ LLC CTYM PS | 2,826,157 10.59% | 2,826,157 (New Position) | View |
| 2019-05-22 5:16 pm Purchase | 13G | QUINCE THERAPEUTICS, INC QNCX | PFIZER INC PFE | 3,249,973 12.2% | 3,249,973 (New Position) | View |
| 2019-05-20 1:18 pm Purchase | 13G | QUINCE THERAPEUTICS, INC QNCX | TAKEDA PHARMACEUTICAL CO LTD TAK | 2,679,802 9.9% | 2,679,802 (New Position) | View |